Autoimmune rheumatic diseases (ARDs) involve multiple organs including the heart and
vasculature. Despite novel treatments, patients with ARDs still experience a reduced life …

Breast cancer is still a lethal disease and the leading cause of death in women, undermining
patients' survival and quality of life. Modern techniques of surgery and radiotherapy allow for …

Simple Summary With nonspecific activation of the immune system, immune checkpoint
inhibitors (ICIs) can lead to off-target immune-related adverse events (irAEs) to every organ …

Myocarditis associated with the use of immune checkpoint inhibitors (ICI) is a rare
manifestation of their cardiotoxicity, but is characterized by a high mortality rate. A literature …

Simple Summary This article investigates the cutaneous adverse immune effects induced by
immune checkpoint inhibitors. These drugs target proteins expressed on cancer cells that …

Abstract Purpose of Review Immune checkpoint inhibitors (ICIs) have improved the field of
cancer, especially in patients with advanced malignancies. Nevertheless, cardiovascular …

The introduction of immune checkpoint inhibitors (ICIs) has revolutionized cancer treatment
standards and significantly enhanced patient prognoses. However, the utilization of these …

Endomyocardial biopsy as the cornerstone of diagnostics has been re-evaluated throughout
the years, leaving unanswered questions on the precedence of it. The reported incidence of …

Immune checkpoint inhibitors (ICIs), pembrolizumab in particular, have been shown to be
vastly more efficacious than traditional cytotoxic or platinum-based chemotherapies in the …

Immune checkpoint inhibitors (ICIs) are specialized monoclonal antibodies (mAbs) that
target immune checkpoints and their ligands, counteracting cancer cell-induced T-cell …